EXCLUSIVE DISTRIBUTION AGREEMENTExclusive Distribution Agreement • April 11th, 2013 • Kamada LTD • Pharmaceutical preparations • England
This EXCLUSIVE DISTRIBUTION AGREEMENT (this “Agreement”) is made and entered into as of August 2, 2012 (the “Effective Date”) by and between Kamada Ltd., an Israeli corporation (collectively with its Affiliates, “Kamada”), whose principal office is at Science Park, Kiryat Weizmann, 7 Sapir Street, Ness Ziona 74140, Israel, and Chiesi Farmaceutici S.p.A (“Chiesi”), an Italian corporation whose registered office is at Via Palermo 26/A, 43122 Parma, Italy.
FRACTION IV-1 PASTE SUPPLY AGREEMENTFraction Iv-1 Paste Supply Agreement • April 11th, 2013 • Kamada LTD • Pharmaceutical preparations • London
This Fraction IV-1 Paste Supply Agreement is entered into, and effective as of this 3rd day of December, 2012 (“Effective Date”), by and between Baxter Healthcare S.A., a Swiss entity, having a place of business at Postfach, 8010 Zurich, Switzerland (“Baxter”) and Kamada Ltd., having a place of business at 7 Sapir St. Kiryat Weizmann, Ness-Ziona 74036, Israel (“Kamada”).
SUPPLY AND DISTRIBUTION AGREEMENTSupply and Distribution Agreement • April 11th, 2013 • Kamada LTD • Pharmaceutical preparations • New York
THIS SUPPLY AND DISTRIBUTION AGREEMENT (this “Agreement”) is entered into this 18th day of July 2011, by and between Kamada Ltd., a corporation organized and existing under the laws of Israel (“Kamada”) and Kedrion S.p.A., a corporation organized and existing under the laws of the Republic of Italy (“Kedrion”), together the “Parties” and each individually a “Party.”
AMENDED AND RESTATED FRACTION IV-1 PASTE SUPPLY AGREEMENTPaste Supply Agreement • April 11th, 2013 • Kamada LTD • Pharmaceutical preparations • New York
This Amended and Restated Fraction IV-1 Paste Supply Agreement (this “Agreement”) is entered into, and effective as of 5:00 PM Eastern Daylight Time, August 23, 2010 (the “Effective Date”), by and between Baxter Healthcare Corporation, a Delaware corporation, having a place of business at One Baxter Way, Westlake Village, California 91361 (“Baxter”) and Kamada Ltd., having a place of business at 7 Sapir St. Kiryat Weizmann, Ness-Ziona 74036, Israel (“Kamada”). Baxter and Kamada are each referred to herein as a “Party” and collectively as the “Parties”.
SECOND AMENDMENT TO THE AMENDED AND RESTATED FRACTION IV-1 PASTE SUPPLY AGREEMENTPaste Supply Agreement • April 11th, 2013 • Kamada LTD • Pharmaceutical preparations
This Second Amendment to the Amended and Restated Fraction IV-1 Paste Supply Agreement (“Second Amendment”) effective this 22nd day of June, 2011 (“Effective Date”), by and between Baxter Healthcare Corporation having a place of business at One Baxter Way, Westlake Village, California 91361 (hereinafter “BAXTER”), and Kamada Ltd., having a place of business at Science Park, Kiryat Weizmann, 7 Sapir St., Ness-Ziona, 74036, Israel (hereinafter “KAMADA”). BAXTER and KAMADA shall collectively be referred to as the “Parties”.
English Summary of a lease agreement dated January 30, 2011, by and between the Israel Land Authority and Kamada Assets (2001) Ltd. (the “Agreement”)Kamada LTD • April 11th, 2013 • Pharmaceutical preparations
On January 30, 2011, the Israel Land Authority (the “Landlord”) and Kamada Assets (2001) Ltd. (the “Tenant” and together, the “Parties”) entered into the Agreement for the lease of certain land in Kibbutz Beit Kama. The Agreement incorporates the standard lease terms published by the Landlord in the Official Gazette no. 4818 from November 4, 1999. Set forth below is a summary of the Agreement.
LICENSE AGREEMENTLicense Agreement • April 11th, 2013 • Kamada LTD • Pharmaceutical preparations • New York
This License Agreement (this "Agreement") is made and entered into as of November 16, 2006 (the "Effective Date") by and between PARI GmbH Spezialisten für effektive Inhalation (hereinafter called "PARI") a German corporation with principal offices at Moosstrasse 3, 82319 Starnberg, Germany, and Kamada Ltd. (hereinafter called "Kamada"), an Israeli company with principal offices at 7 Sapir St., Kiryat Weizmann Science Park, Ness-Ziona – ISRAEL.
Amendment No. 1 to the License Agreement of November 16, 2006 (the "License Agreement") between PARI Pharma GmbH and Kamada Ltd.License Agreement • April 11th, 2013 • Kamada LTD • Pharmaceutical preparations
WHEREAS the parties wish to extend the period during which they shall negotiate in good faith the terms and conditions of a Supply Agreement, as stipulated in Section 6.4 of the License Agreement;
FIRST AMENDMENT TO THE AMENDED AND RESTATED FRACTION IV-1 PASTE SUPPLY AGREEMENTPaste Supply Agreement • April 11th, 2013 • Kamada LTD • Pharmaceutical preparations
This First Amendment to the Amended and Restated Fraction IV-1 Paste Supply Agreement (“First Amendment”) effective this 10th day of May, 2011 (“Effective Date”), by and between Baxter Healthcare Corporation having a place of business at One Baxter Way, Westlake Village, California 91361 (hereinafter “BAXTER”), and Kamada Ltd., having a place of business at Science Park, Kiryat Weizmann, 7 Sapir St., Ness-Ziona, 74036, Israel (hereinafter “KAMADA”). BAXTER and KAMADA shall collectively be referred to as the "Parties”.
